Kaposi's sarcoma is a common manifestation of the acquired immunodeficiency syndrome (AIDS). It occurs in up to a quarter of patients with AIDS, being particularly common in homosexual and bisexual men.' It usually presents with cutaneous lesions, with the gut and lymph nodes frequently affected. Kaposi's sarcoma may attack the lungs, pleura, and tracheobronchial tree, so it should be considered in the differential diagnosis of respiratory disease in patients who are HIV-1 seropositive. The true incidence of intrathoracic lesions in patients with Kaposi's sarcoma is difficult to assess. A postmortem study found pulmonary Kaposi's sarcoma in 47% of patients with cutaneous disease.2 In clinical studies pulmonary Kaposi's sarcoma has been described in 3-13% of patients with AIDS overall,34 in 6-32% of patients with AIDS and cutaneous Kaposi's sarcoma,356 and in about 10% of patients with AIDS and respiratory symptoms. 4 
Symptoms
All 19 patients had cough and breathlessness. Two patients had anterior chest pain and one had haemoptysis. The overall duration of symptoms ranged from 2 to 20 (median 4) weeks. In patients with local endobronchial Kaposi's sarcoma, symptoms had lasted 2-12 (median 8) weeks and in patients with extensive Kaposi's sarcoma 2-20 (median 4) weeks (NS). The time from diagnosis of cutaneous Kaposi's sarcoma to discovery of endobronchial sarcoma at bronchoscopy ranged from 2 to 29 (median 12) months in those with local endobronchial Kaposi's sarcoma and from 3 to 19 (median 10) months in those with extensive endobronchial sarcoma (NS).
Lungfunction and radiographicfindings
The peak flow, FEV1, and FVC were normal in patients with local endobronchial Kaposi's sarcoma, but were reduced in patients with extensive disease (p < 001, <005, and <005), whereas TLCO was reduced in both groups of patients, with lesser reductions in Kco (table) . The lung function abnormalities were attributed to pulmonary Kaposi's sarcoma in the 15 patients where no other pathological findings emerged. The pneumocystis pneumonia found in the other four patients provides an additional source of lung function abnormality. Various abnormalities were seen on the chest radiograph. Four patients with local endobronchial lesions had a normal chest radiograph, whereas coarse, irregular bilateral shadows were seen only in patients with extensive endobronchial disease. TREATMENT From that time onwards I have somehow managed to combine sophisticated medicine in Britain with work in third world countries. This has meant working hard in London for a long stretch and then, about every other year, taking offa month or so to go on an expedition to some remote part of the world. It is a rewarding combination and I would fully recommend a spell of practising medicine in the developing world to any registrar despairing of an immediate consultant job here in Britain.
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